Pharmaceuticals
- 441
- Test-med Vaccination Services Medical Corp
- Offers at site vaccination services to corporate clients and the community through local partnerships with shopping malls, pharmacies, school and civic organizations.
- 442
- The Traveling Physician
- Providers of vaccines for yellow fever, rabies, Japanese B encephalitis. Also supplies both oral and injected typhoid vaccines.
- 443
- Generex Biotechnology
- Developed a proprietary technology to administer large molecule drugs, including hormone proteins, peptides, monoclonal antibodies and vaccines as a mist absorbed in the buccal mucosa. Overview of production, aims and investor data of company in Toronto, Ontario.
- 444
- Affinium Pharmaceuticals
- Developer of a novel class of antibiotics, under license to major manufacturers. Including marketing profile, news archive and contacts in Toronto, Canada.
- 445
- Aphios Corp.
- Developing natural therapeutics, with a focus on infectious diseases, cancer and quality-of-life medicines. Overview of extraction and nanoscale technologies, product pipeline and profile of company in Woburn, Massachusetts.
- 446
- AplaGen Biopharmaceuticals
- Development of cytokine analogs for cancer therapy, peptides for contraception, diagnosis and treatment of infertility. Includes introduction to technology, projects, key staff, and contacts for careers in Baesweiler, Germany.
- 447
- BioMarin Pharmaceutical Inc.
- Researches and develops therapies for debilitating, fatal, chronic genetic disorders causing enzyme deficiency of carbohydrate metabolism, such as phenylketonuria. Headquarters in Novato, California. (Nasdaq: BMRN).
- 448
- Biotech Concepts GmbH.
- Company engaged in the development of nutraceuticals, novel anti-infectives, such as the enzymatic modification of existing antibiotics. Domiciled in Zurich, Switzerland
- 449
- Dongbao Enterprise Group Co., Ltd.
- Conglomerate industrial group, with more than 20 subsidiaries, engaged in the field of pharmaceutical production and manufacturers of recombinants, especially human insulin in Shanghai, China.
- 450
- Ligand Pharmaceuticals Inc.
- Company developing small-molecule drugs and recombinant DNA proteins, which regulate gene activity and genetic processes in cancer and other diseases. Includes product information for patients and professionals from San Diego, California. (Nasdaq: LGND)
- 451
- NPS Pharmaceuticals, Inc.
- Discovers and develops drugs targeting skeletal, endocrinological, gastrointestinal, and central nervous system. Includes glossary, stages in pipeline, careers in North America, and investment in Salt Lake City, Utah. (Nasdaq: NPSP).
- 452
- Progenics Pharmaceuticals Inc.
- Develops and commercializes innovative products for the treatment of melanoma, prostate cancer, viral diseases, including HIV. Information for investors, and details of the company in Tarrytown, New York. (Nasdaq: PGNX)
- 453
- Repligen Corporation
- Researches, develops, manufactures and markets synthetic version of protein A for monoclonal antibody processing, and peptides such as secretin for gastrointestinal and pediatric neurology. Details for investors and clinical programs run from Waltham Massachusetts. (Nasdaq: RGEN)
- 454
- SciClone Pharmaceuticals, Inc.
- Develops and markets products targeted for treatment of cancer and diseases such as hepatitis B and C, cystic fibrosis and immune system disorders. Based in San Mateo, California. (Nasdaq: SCLN)
- 455
- Biopharma: Biopharmaceuticals in the U.S. Market
- Online reference database and book concerning products and companies. Includes sample monographs. ordering details and contacts for publisher in Rockville, Maryland.
- 456
- Bioreliance Corp.
- Provides nonclinical testing and manufacturing services for biologics. Contract facilities in Scotland and Germany, with laboratory animal diagnostic services, and headquarters in Rockville, Maryland.
- 457
- Cambrex Life Sciences Corp.
- Offers analytical and cell culture products and contract services to the life sciences industry. Includes product, management, corporate, and investor information, for many countries, with headquarters in East Rutherford, New Jersey. (NYSE: CBM)
- 458
- Insmed, Inc.
- Protein manufacturing facility concentrated on developing treatments for metabolic and endocrine disorders. Details of investor relations and cGMP process manufacturing at Boulder, Colorado. (Nasdaq: INSM)